Market Cap
$88.79 Billion
USD as of July 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$329.83 B |
![]() |
$85.00 B |
Marinomed Biotech AG | $84.73 B |
![]() |
$78.88 B |
![]() |
$46.56 B |
Company | Market Cap (USD) |
---|---|
![]() |
$428.70 B |
![]() |
$417.05 B |
![]() |
$412.24 B |
![]() |
$329.83 B |
![]() |
$275.82 B |
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Vertex Pharmaceuticals Incorporated is a pharmaceuticals and biotherapeutics company. It notably produces drugs and genetic therapies for cystic fibrosis and other skin conditions, such as pain, sickle cell disease, beta-thalassemia, hormonal deficiencies, kidney diseases, Duchenne muscular dystrophy, and diabetes.
Vertex Pharmaceuticals Incorporated has the following listings and related stock indices.
Stock: NASDAQ: VRTX
Stock: FSX: VX1
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.